Symbol: |
CYP2A7
|
Description: |
cytochrome P450, family 2, subfamily A, polypeptide 7 [Source:HGNC Symbol;Acc:2611]
|
Location: |
Chr19:41381344-41388657[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:382
Gene |
Compound |
Gen_sig |
Exp_pattern |
CYP2A7 |
NSC 11850 |
0.037 |
Down |
CYP2A7 |
NSC 11865 |
0.035 |
Down |
CYP2A7 |
NSC 119621 |
0.033 |
Up |
CYP2A7 |
NSC 119911 |
0.008 |
Down |
CYP2A7 |
NSC 119915 |
0.031 |
Down |
CYP2A7 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.003 |
Down |
CYP2A7 |
VERNOLIDE |
0.003 |
Down |
CYP2A7 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.001 |
Down |
CYP2A7 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.023 |
Down |
CYP2A7 |
NSC 135371 |
0.014 |
Down |
CYP2A7 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.002 |
Down |
CYP2A7 |
TZT |
0.001 |
Down |
CYP2A7 |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.026 |
Down |
CYP2A7 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.005 |
Down |
CYP2A7 |
NSC 166382 |
0.011 |
Down |
Expression pattern: Sensitivity / Resistance
Total:26 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:29
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:102
Total:7 Current:1
[First] [Prev]  Next Last 
|